Hospitalizations for Cardiovascular Diseases During the Early Stage of the COVID-19 Pandemic in Japan
Open Access
- 30 June 2022
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 4 (8) , 353-362
Abstract
Background: Although reductions in hospitalizations for myocardial infarction and heart failure have been reported during the period of COVID-19 pandemic restrictions, it is unclear how the overall number of hospitalizations for cardiovascular disease (CVD) treatment changed in the early stages of the pandemic.Methods and Results: We analyzed the records of 574 certified hospitals affiliated with the Japanese Circulation Society and retrieved data from April 2015 to March 2020. Records were obtained from the nationwide Japanese Registry of All Cardiac and Vascular Diseases–Diagnosis Procedure Combination database. A quasi-Poisson regression model was used to estimate the number of hospitalizations for CVD treatment. Between January and March 2020, when the number of COVID-19 cases was relatively low in Japan, the actual/estimated number of hospitalizations for acute CVD was 18,233/21,634 (84.3%), whereas the actual/estimated number of scheduled hospitalizations was 16,921/19,066 (88.7%). The number of hospitalizations for acute heart failure and scheduled hospitalizations for valvular disease and aortic aneurysm were 81.1%, 84.6%, and 83.8% of the estimated values, respectively. A subanalysis that considered only facilities without hospitalization restrictions did not alter the results for these diseases.Conclusions: The spread of COVID-19 was associated with a decreased number of hospitalizations for CVD in Japan, even in the early stages of the pandemic.Keywords
This publication has 15 references indexed in Scilit:
- Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) ― Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society ―Circulation Reports, 2021
- Trends in suicide in Japan by gender during the COVID-19 pandemic, up to September 2020Psychiatry Research, 2021
- Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMIJACC, 2020
- Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in ChinaJACC, 2020
- Temporal trends in decompensated heart failure and outcomes during COVID‐19: a multisite report from heart failure referral centres in LondonEuropean Journal of Heart Failure, 2020
- Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020Eurosurveillance, 2020
- Coronavirus Disease 2019 (COVID-19) Information for Cardiologists ― Systematic Literature Review and Additional Analysis ―Circulation Journal, 2020
- Influenza‐associated mortality determined from all‐cause mortality, Denmark 2010/11‐2016/17: The FluMOMO modelInfluenza and Other Respiratory Viruses, 2018
- Heart Failure as a General Pandemic in AsiaEuropean Journal of Heart Failure, 2015
- Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011Epidemiology and Infection, 2012